Do I Have to Take Ozempic Forever?

It's one of the most-searched questions about these drugs, and it usually gets a slippery answer. Here's a straight one, grounded in the trials that actually studied what happens when people stop.

The honest answer: for most people, the benefits last as long as the drug does

GLP-1 medications treat chronic conditions, obesity and type 2 diabetes. The drug works while you take it, and the evidence is consistent that the weight and metabolic gains fade after stopping. This isn't a course of antibiotics you finish. It's closer to a blood-pressure medication that keeps working because you keep taking it.

What the trials show when people stop

The discontinuation studies are worth knowing, and they point the same direction. In STEP 4, people who stopped semaglutide after the initial phase regained a large share of the weight they'd lost, while those who continued kept losing (Rubino 2021). In SURMOUNT-4, stopping tirzepatide led to substantial regain, and continuing led to further loss (Aronne 2024). The STEP 1 extension found participants regained roughly two-thirds of their lost weight within about a year of stopping the drug and support (Wilding 2022). Stop the drug, and the biology it was holding in check tends to return.

Why this happens, and why it isn't a failure

Obesity involves hormonal set-points that push the body back toward its prior weight. A GLP-1 counteracts those signals. Remove it, and the signals reassert themselves. Regaining weight after stopping isn't a lack of willpower or proof the drug "didn't work." It's the expected physiology of treating a chronic condition with a drug that acts while it's present. Calling it personal failure gets the biology wrong.

Where a CGM fits the honest version

If you wear a continuous glucose monitor, this story becomes visible instead of abstract. The sensor shows the benefit while you're on the drug, with flatter post-meal curves and more time in range, and it will show those gains soften if you come off. That's not a reason to hide the come-off data. It's a reason to trust the monitoring, because the CGM's value tracks the drug's real pharmacology: it documents what's actually happening, on the drug and off it.

So what are the options?

"Forever" isn't the only frame. Some people stay on a maintenance dose long-term. Some work with their clinician toward the lowest effective dose. Some use time on the drug to build habits, though the trials are honest that habits alone rarely hold the full loss against the hormonal pushback. What the evidence doesn't support is the idea that a few months permanently fixes the underlying condition. That decision belongs with you and your clinician, made with the real data in front of you.

For most people, then, a GLP-1's benefits last as long as they take it, and stopping usually brings meaningful regain, around two-thirds of lost weight in the longest study. That's not a scare tactic. It's the same logic as any chronic-condition medication, and knowing it up front is what lets you make a real decision instead of a disappointed one.